AlloVir (ALVR) Insider Trading & Ownership → A new way to collect income from stocks (From DTI) (Ad) Free alvr Stock Alerts $0.77 +0.01 (+0.83%) (As of 10:52 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AlloVir (NASDAQ:ALVR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage39.97%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$10.99 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$275,701.48 Get ALVR Insider Trade Alerts Want to know when executives and insiders are buying or selling AlloVir stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALVR Insider Buying and Selling by Quarter Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. AlloVir Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/2/2024Brett R HagenCAOSell281$0.77$216.37 4/2/2024Diana BrainardCEOSell1,533$0.77$1,180.41 4/2/2024Edward MillerGeneral CounselSell368$0.77$283.36 4/2/2024Vikas SinhaInsiderSell885$0.77$681.45 2/8/2024Brett R HagenCAOSell11,150$0.67$7,470.50 2/5/2024Brett R HagenCAOSell5,792$0.67$3,880.64 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/5/2024Diana BrainardCEOSell41,421$0.67$27,752.07 2/5/2024Edward MillerGeneral CounselSell8,869$0.67$5,942.23 2/5/2024Vikas SinhaInsiderSell18,331$0.67$12,281.77 1/23/2024Brett R HagenCAOSell901$0.67$603.67 1/23/2024Diana BrainardCEOSell9,500$0.67$6,365.00 1/23/2024Edward MillerGeneral CounselSell1,302$0.67$872.34 1/23/2024Vikas SinhaInsiderSell3,205$0.67$2,147.35 1/4/2024Brett R HagenCAOSell310$0.64$198.40 1/4/2024Diana BrainardCEOSell1,664$0.64$1,064.96 1/4/2024Edward MillerGeneral CounselSell424$0.64$271.36 1/4/2024Vikas SinhaInsiderSell961$0.64$615.04 11/20/2023Diana BrainardCEOSell4,382$1.69$7,405.58 11/17/2023Brett R HagenCAOSell403$1.63$656.89 11/17/2023Diana BrainardCEOSell2,689$1.63$4,383.07 11/17/2023Vikas SinhaInsiderSell2,490$1.63$4,058.70 10/19/2023Brett R HagenCAOSell358$1.58$565.64 10/19/2023Diana BrainardCEOSell8,581$1.58$13,557.98 10/19/2023Vikas SinhaInsiderSell1,232$1.58$1,946.56 10/3/2023Brett R HagenCAOSell222$1.98$439.56 10/3/2023Diana BrainardCEOSell1,325$1.98$2,623.50 10/3/2023Vikas SinhaInsiderSell755$1.98$1,494.90 8/17/2023Brett R HagenCAOSell1,653$2.50$4,132.50 8/17/2023Diana BrainardCEOSell11,361$2.50$28,402.50 8/17/2023Vikas SinhaInsiderSell10,516$2.50$26,290.00 7/19/2023Brett R HagenCAOSell342$3.56$1,217.52 7/19/2023Diana BrainardCEOSell8,342$3.56$29,697.52 7/19/2023Vikas SinhaInsiderSell1,198$3.56$4,264.88 7/5/2023Diana BrainardCEOSell5,275$3.05$16,088.75 7/5/2023Vikas SinhaInsiderSell2,983$3.05$9,098.15 6/27/2023Gilead Sciences, Inc.Major ShareholderBuy2,930,870$3.75$10,990,762.50 6/9/2023Brett R HagenCAOSell5,045$5.64$28,453.80 5/18/2023Diana BrainardCEOSell4,536$4.21$19,096.56 (Data available from 1/1/2013 forward) ALVR Insider Trading Activity - Frequently Asked Questions Who is on AlloVir's Insider Roster? The list of insiders at AlloVir includes Agustin Melian, Ann M Leen, Beek Jeroen B Van, Brett R Hagen, David Hallal, Diana Brainard, Edward Miller, Ercem Atillasoy, Gilead Sciences, Inc., Jeffrey S Bornstein, Morana Jovan-Embiricos, and Vikas Sinha. Learn more on insiders at ALVR. What percentage of AlloVir stock is owned by insiders? 39.97% of AlloVir stock is owned by insiders. Learn more on ALVR's insider holdings. Which AlloVir insiders have been buying company stock? The following insiders have purchased ALVR shares in the last 24 months: Gilead Sciences, Inc. ($10,990,762.50), and Jeffrey S Bornstein ($23,200.00). How much insider buying is happening at AlloVir? Insiders have purchased a total of 2,935,870 ALVR shares in the last 24 months for a total of $11,013,962.50 bought. Which AlloVir insiders have been selling company stock? The following insiders have sold ALVR shares in the last 24 months: Beek Jeroen B Van ($305,683.25), Brett R Hagen ($220,209.63), David Hallal ($8,032,529.91), Diana Brainard ($558,136.62), Edward Miller ($43,877.71), and Vikas Sinha ($114,381.11). How much insider selling is happening at AlloVir? Insiders have sold a total of 1,346,369 AlloVir shares in the last 24 months for a total of $9,274,818.23 sold. More Insider Trading Tools from MarketBeat Related Companies: PLX Insider Selling CVM Insider Selling ATRA Insider Selling ATHA Insider Selling DTIL Insider Selling CRIS Insider Selling PASG Insider Selling GRTS Insider Selling CGTX Insider Selling SGMO Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:ALVR) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AlloVir, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.